Neil Stahl - Aug 8, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Neil E. Stahl
Stock symbol
REGN
Transactions as of
Aug 8, 2024
Transactions value $
-$5,636,346
Form type
4
Date filed
8/12/2024, 04:05 PM
Previous filing
Aug 6, 2024
Next filing
Aug 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$108K -100 -0.18% $1,081.83 56.1K Aug 8, 2024 Direct F1
transaction REGN Common Stock Sale -$217K -200 -0.36% $1,082.69 55.9K Aug 8, 2024 Direct F2
transaction REGN Common Stock Sale -$1.09M -1.01K -1.8% $1,083.76 54.9K Aug 8, 2024 Direct F3
transaction REGN Common Stock Sale -$2.04M -1.88K -3.43% $1,084.61 53K Aug 8, 2024 Direct F4
transaction REGN Common Stock Sale -$1.85M -1.71K -3.22% $1,085.01 51.3K Aug 8, 2024 Direct F5
transaction REGN Common Stock Sale -$326K -300 -0.58% $1,086.15 51K Aug 8, 2024 Direct F6
transaction REGN Common Stock Gift $0 -900 -1.76% $0.00 50.1K Aug 12, 2024 Direct
holding REGN Common Stock 5.85K Aug 8, 2024 By 401(k) Plan
holding REGN Common Stock 4.61K Aug 8, 2024 by Spouse as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 100 shares of Company stock on August 8, 2024 at prices ranging from $1,081.75 to $1,081.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
F2 Represents volume-weighted average price of sales of 200 shares of Company stock on August 8, 2024 at prices ranging from $1,082.65 to $1,082.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 1,006 shares of Company stock on August 8, 2024 at prices ranging from $1,083.27 to $1,083.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 1,883 shares of Company stock on August 8, 2024 at prices ranging from $1,084.01 to $1,084.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 1,708 shares of Company stock on August 8, 2024 at prices ranging from $1,085.00 to $1,085.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
F6 Represents volume-weighted average price of sales of 300 shares of Company stock on August 8, 2024 at prices ranging from $1,086.14 to $1,086.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.